A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection
Purpose: Human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) is associated with unfavorable prognosis, while independent prognostic markers remain to be defined. Experimental Design: We retrospectively performed miRNA expression profiling. Patients were operated for loc...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
March 2019
|
| In: |
Clinical cancer research
Year: 2019, Jahrgang: 25, Heft: 5, Pages: 1505-1516 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-18-0776 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1158/1078-0432.CCR-18-0776
|
| Verfasserangaben: | Julia Hess, Kristian Unger, Cornelius Maihoefer, Lars Schuettrumpf, Ludmila Wintergerst, Theresa Heider, Peter Weber, Sebastian Marschner, Herbert Braselmann, Daniel Samaga, Sebastian Kuger, Ulrike Pflugradt, Philipp Baumeister, Axel Walch, Christine Woischke, Thomas Kirchner, Martin Werner, Kristin Werner, Michael Baumann, Volker Budach, Stephanie E. Combs, Juergen Debus, Anca-Ligia Grosu, Mechthild Krause, Annett Linge, Claus Roedel, Martin Stuschke, Daniel Zips, Horst Zitzelsberger, Ute Ganswindt, Michael Henke, and Claus Belka |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1662801912 | ||
| 003 | DE-627 | ||
| 005 | 20230426154241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190404s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/1078-0432.CCR-18-0776 |2 doi | |
| 035 | |a (DE-627)1662801912 | ||
| 035 | |a (DE-599)KXP1662801912 | ||
| 035 | |a (OCoLC)1341207892 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Heß, Julia |d 1983- |e VerfasserIn |0 (DE-588)1027212743 |0 (DE-627)728604833 |0 (DE-576)372618189 |4 aut | |
| 245 | 1 | 2 | |a A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection |c Julia Hess, Kristian Unger, Cornelius Maihoefer, Lars Schuettrumpf, Ludmila Wintergerst, Theresa Heider, Peter Weber, Sebastian Marschner, Herbert Braselmann, Daniel Samaga, Sebastian Kuger, Ulrike Pflugradt, Philipp Baumeister, Axel Walch, Christine Woischke, Thomas Kirchner, Martin Werner, Kristin Werner, Michael Baumann, Volker Budach, Stephanie E. Combs, Juergen Debus, Anca-Ligia Grosu, Mechthild Krause, Annett Linge, Claus Roedel, Martin Stuschke, Daniel Zips, Horst Zitzelsberger, Ute Ganswindt, Michael Henke, and Claus Belka |
| 264 | 1 | |c March 2019 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.04.2019 | ||
| 520 | |a Purpose: Human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) is associated with unfavorable prognosis, while independent prognostic markers remain to be defined. Experimental Design: We retrospectively performed miRNA expression profiling. Patients were operated for locally advanced HPV-negative HNSCC and had received radiochemotherapy in eight different hospitals (DKTK-ROG; n = 85). Selection fulfilled comparable demographic, treatment, and follow-up characteristics. Findings were validated in an independent single-center patient sample (LMU-KKG; n = 77). A prognostic miRNA signature was developed for freedom from recurrence and tested for other endpoints. Recursivepartitioning analysis was performed on the miRNA signature, tumor and nodal stage, and extracapsular nodal spread. Technical validation used qRT-PCR. An miRNA-mRNA target network was generated and analyzed. Results: For DKTK-ROG and LMU-KKG patients, the median follow-up was 5.1 and 5.3 years, and the 5-year freedom from recurrence rate was 63.5% and 75.3%, respectively. A five-miRNA signature (hsa-let-7g-3p, hsamiR- 6508-5p, hsa-miR-210-5p, hsa-miR-4306, and hsa-miR-7161-3p) predicted freedom from recurrence in DKTK-ROG [hazard ratio (HR) 4.42; 95% confidence interval (CI), 1.98-9.88, P < 0.001], which was confirmed in LMU-KKG (HR 4.24; 95% CI, 1.40-12.81, P = 0.005). The signature also predicted overall survival (HR 3.03; 95% CI, 1.50-6.12, P = 0.001), recurrence-free survival (HR 3.16; 95% CI, 1.65-6.04, P < 0.001), and disease-specific survival (HR 5.12; 95% CI, 1.88-13.92, P < 0.001), all confirmed in LMU-KKG data. Adjustment for relevant covariates maintained the miRNA signature predicting all endpoints. Recursive- partitioning analysis of both samples combined classified patients into low (n = 17), low-intermediate (n = 80), high-intermediate (n = 48), or high risk (n = 17) for recurrence (P < 0.001). Conclusions: The five-miRNA signature is a strong and independent prognostic factor for disease recurrence and survival of patients with HPV-negative HNSCC. | ||
| 650 | 4 | |a hsa-mir-210 | |
| 650 | 4 | |a hypoxia | |
| 650 | 4 | |a identification | |
| 650 | 4 | |a microrna expression | |
| 650 | 4 | |a oropharyngeal cancer | |
| 650 | 4 | |a prognostic-factor | |
| 650 | 4 | |a progression | |
| 650 | 4 | |a risk | |
| 650 | 4 | |a squamous-cell carcinoma | |
| 650 | 4 | |a validation | |
| 700 | 1 | |a Unger, Kristian |d 1977- |e VerfasserIn |0 (DE-588)138244340 |0 (DE-627)600663485 |0 (DE-576)306878399 |4 aut | |
| 700 | 1 | |a Combs, Stephanie |d 1976- |e VerfasserIn |0 (DE-588)124782515 |0 (DE-627)366051245 |0 (DE-576)294499741 |4 aut | |
| 700 | 1 | |a Debus, Jürgen |d 1964- |e VerfasserIn |0 (DE-588)1022671421 |0 (DE-627)717025780 |0 (DE-576)365774944 |4 aut | |
| 700 | 1 | |a Grosu, Anca-Ligia |e VerfasserIn |0 (DE-588)122079051 |0 (DE-627)512028990 |0 (DE-576)293080933 |4 aut | |
| 700 | 1 | |a Linge, Annett |d 1981- |e VerfasserIn |0 (DE-588)1147092605 |0 (DE-627)1008474398 |0 (DE-576)285600125 |4 aut | |
| 700 | 1 | |a Rödel, Claus |d 1966- |e VerfasserIn |0 (DE-588)1152978330 |0 (DE-627)101434705X |0 (DE-576)499988248 |4 aut | |
| 700 | 1 | |a Stuschke, Martin |e VerfasserIn |0 (DE-588)116745961X |0 (DE-627)1031131183 |0 (DE-576)511163312 |4 aut | |
| 700 | 1 | |a Zips, Daniel |d 1970- |e VerfasserIn |0 (DE-588)1160262535 |0 (DE-627)102341404X |0 (DE-576)505812681 |4 aut | |
| 700 | 1 | |a Zitzelsberger, Horst |d 1963- |e VerfasserIn |0 (DE-588)172608643 |0 (DE-627)697543285 |0 (DE-576)13346797X |4 aut | |
| 700 | 1 | |a Ganswindt, Ute |d 1967- |e VerfasserIn |0 (DE-588)122619927 |0 (DE-627)705973638 |0 (DE-576)293351376 |4 aut | |
| 700 | 1 | |a Henke, Michael |e VerfasserIn |0 (DE-588)1132084539 |0 (DE-627)887360602 |0 (DE-576)488602777 |4 aut | |
| 700 | 1 | |a Belka, Claus |e VerfasserIn |0 (DE-588)143654829 |0 (DE-627)65383604X |0 (DE-576)176701877 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical cancer research |d Philadelphia, Pa. [u.a.] : AACR, 1995 |g 25(2019), 5, Seite 1505-1516 |h Online-Ressource |w (DE-627)325489971 |w (DE-600)2036787-9 |w (DE-576)094502234 |x 1557-3265 |7 nnas |a A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection |
| 773 | 1 | 8 | |g volume:25 |g year:2019 |g number:5 |g pages:1505-1516 |g extent:12 |a A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection |
| 856 | 4 | 0 | |u https://doi.org/10.1158/1078-0432.CCR-18-0776 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190404 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1022671421 |a Debus, Jürgen |m 1022671421:Debus, Jürgen |d 910000 |d 911400 |e 910000PD1022671421 |e 911400PD1022671421 |k 0/910000/ |k 1/910000/911400/ |p 22 | ||
| 998 | |g 124782515 |a Combs, Stephanie |m 124782515:Combs, Stephanie |d 910000 |d 950000 |d 950950 |e 910000PC124782515 |e 950000PC124782515 |e 950950PC124782515 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950950/ |p 21 | ||
| 999 | |a KXP-PPN1662801912 |e 3418056385 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Julia","display":"Heß, Julia","role":"aut","family":"Heß"},{"role":"aut","family":"Unger","display":"Unger, Kristian","given":"Kristian"},{"display":"Combs, Stephanie","given":"Stephanie","role":"aut","family":"Combs"},{"role":"aut","family":"Debus","display":"Debus, Jürgen","given":"Jürgen"},{"family":"Grosu","role":"aut","display":"Grosu, Anca-Ligia","given":"Anca-Ligia"},{"display":"Linge, Annett","given":"Annett","role":"aut","family":"Linge"},{"role":"aut","family":"Rödel","given":"Claus","display":"Rödel, Claus"},{"given":"Martin","display":"Stuschke, Martin","role":"aut","family":"Stuschke"},{"role":"aut","family":"Zips","display":"Zips, Daniel","given":"Daniel"},{"family":"Zitzelsberger","role":"aut","given":"Horst","display":"Zitzelsberger, Horst"},{"given":"Ute","display":"Ganswindt, Ute","role":"aut","family":"Ganswindt"},{"display":"Henke, Michael","given":"Michael","family":"Henke","role":"aut"},{"display":"Belka, Claus","given":"Claus","family":"Belka","role":"aut"}],"relHost":[{"recId":"325489971","id":{"issn":["1557-3265"],"zdb":["2036787-9"],"eki":["325489971"]},"title":[{"title_sort":"Clinical cancer research","title":"Clinical cancer research"}],"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"language":["eng"],"part":{"issue":"5","extent":"12","year":"2019","volume":"25","pages":"1505-1516","text":"25(2019), 5, Seite 1505-1516"},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1995","dateIssuedDisp":"1995-","publisherPlace":"Philadelphia, Pa. [u.a.]","publisher":"AACR"}],"disp":"A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infectionClinical cancer research","pubHistory":["1.1995 -"],"physDesc":[{"extent":"Online-Ressource"}],"corporate":[{"role":"isb","display":"American Association for Cancer Research"}],"name":{"displayForm":["American Association for Cancer Research"]}}],"physDesc":[{"extent":"12 S."}],"name":{"displayForm":["Julia Hess, Kristian Unger, Cornelius Maihoefer, Lars Schuettrumpf, Ludmila Wintergerst, Theresa Heider, Peter Weber, Sebastian Marschner, Herbert Braselmann, Daniel Samaga, Sebastian Kuger, Ulrike Pflugradt, Philipp Baumeister, Axel Walch, Christine Woischke, Thomas Kirchner, Martin Werner, Kristin Werner, Michael Baumann, Volker Budach, Stephanie E. Combs, Juergen Debus, Anca-Ligia Grosu, Mechthild Krause, Annett Linge, Claus Roedel, Martin Stuschke, Daniel Zips, Horst Zitzelsberger, Ute Ganswindt, Michael Henke, and Claus Belka"]},"id":{"doi":["10.1158/1078-0432.CCR-18-0776"],"eki":["1662801912"]},"recId":"1662801912","note":["Gesehen am 04.04.2019"],"title":[{"title":"A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection","title_sort":"five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"March 2019","dateIssuedKey":"2019"}]} | ||
| SRT | |a HESSJULIAUFIVEMICROR2019 | ||